Bikash khadka | Medicine and Dentistry | Best Researcher Award

Posted on 10/12/202410/12/2024 by ScienceFather

Dr. Bikash khadka | Medicine and Dentistry | Best Researcher Award

Dr. Bikash khadka , Nepal Mediciti , Nepal

Dr. Bikash Khadka is a dedicated anesthesiologist from Lalitpur, Kathmandu, Nepal, with extensive experience in critical care and perioperative medicine. He earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, in 2018, after completing his MBBS at Kathmandu University School of Medical Sciences in 2012. Dr. Bikash Khadka currently serves as a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital, where he manages a 32-bed mixed ICU and conducts anesthesia for various surgeries. Passionate about medical education, he has also served as a Lecturer at Lumbini Medical College. His research focuses on anesthesia techniques, critical care, and perioperative safety, with numerous published articles in peer-reviewed journals. He is proficient in advanced airway management, regional blocks, and critical patient care. Dr. Bikash Khadka actively participates in medical workshops and conferences to stay updated in his field.

Publication Profile

Scopus

Work Experience

Dr. Bikash Khadka has been a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital since August 2019, where he manages a 32-bed mixed ICU and provides anesthesia for diverse surgeries. From November 2018 to August 2019, he worked as a Lecturer at Lumbini Medical College, teaching anesthesiology to medical students. As a Resident Doctor (2015-2018) at the same institution, he performed pre-anesthetic assessments, anesthesia conduction, ICU management, and supervised junior residents. His responsibilities included emergency surgeries, obstetric analgesia, and critical care. From September 2013 to March 2014, he was a Medical Officer at Alka Hospital, providing emergency care. His experience spans specialized anesthesia services, resuscitation, and managing patients across various surgical and ICU settings.

Education and Training

Dr. Bikash Khadka earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, from 2015 to 2018. Prior to that, he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Kathmandu University School of Medical Sciences between 2008 and 2012. During his medical education, he acquired extensive theoretical knowledge and hands-on experience, laying the foundation for his career in anesthesiology and critical care. His education focused on pre-anesthetic assessment, anesthesia conduction, ICU management, and patient care during complex surgical procedures. Dr. Bikash Khadka also completed significant training, including ACLS, BLS, airway management, and acute care ultrasound workshops, strengthening his proficiency in both clinical and emergency care. His commitment to continual learning is reflected in his active participation in national conferences and specialized courses.

Awards and Training

Dr. Bikash Khadka has attended various prestigious conferences and workshops, including the 17th National Conference of the Society of Anesthesiologists of Nepal (SANCON) in 2016. He participated in specialized workshops like the Difficult Airway Workshop and Acute Care Ultrasound Workshop. He holds certifications in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS), showcasing his dedication to critical care excellence. His commitment to academic excellence is evident through his lecturer role and involvement in training junior residents. Dr. Bikash Khadka’s clinical expertise and research contributions have established him as a respected professional in anesthesiology and critical care in Nepal.

Research Focus

Dr. Bikash Khadka’s research focuses on anesthesiology, critical care, and perioperative management. His interests include optimizing patient outcomes in ICU settings, managing complex airway cases, and preventing anesthesia-related complications. He has contributed to research on rare medical conditions, such as Boerhaave syndrome and post-COVID-19 vaccine complications. Dr. Bikash khadka is also interested in comparative studies on pharmacological agents to improve surgical outcomes, such as using dexmedetomidine and dexamethasone for postoperative nausea prevention. His work often explores innovative approaches to regional anesthesia, patient safety, and critical care protocols. His systematic reviews and case reports provide valuable insights into anesthesia practice and patient management.

Publication Top Notes

Role of pre-operative counseling with NSQIP surgical risk calculator in the surgical patients

Authors: Khadka, B., Sharma, A., Bhattarai, P.R., Rayamajhi, B., Adhikari, H.

Journal: Surgery Open Science

Year: 2024

Volume: 18, pp. 11–16

Citations: 0

Pyopericardium progressing to cardiac tamponade in a patient with dengue fever

Authors: Khadka, B., Khanal, K., Regmi, A., KC, S., Nepal, R.

Journal: IDCases

Year: 2024

Volume: 36, Article e01996

Citations: 0

Removing knotted or stuck epidural catheters: a systematic review of case reports

Authors: Khadka, B., Sharma, A., Regmi, A., Ghimire, A., Bhattarai, P.R.

Journal: Anesthesia and Pain Medicine

Year: 2023

Volume: 18(3), pp. 315–324

Citations: 1

A rare case of Boerhaave syndrome with cervico-thoracic esophageal junction rupture causing bilateral empyema; case report from Nepal

Authors: Khadka, B., Khanal, K., Dahal, P., Adhikari, H.

Journal: International Journal of Surgery Case Reports

Year: 2023

Volume: 105, Article 108018

Citations: 2

Post COVID-19 vaccine Guillain-Barré syndrome

Authors: Khadka, B., Khanal, K.

Journal: Journal of Nepal Health Research Council

Year: 2022

Volume: 19(4), pp. 852–854

Citations:

Chun-Feng Huang | Health Professions | Best Researcher Award

Posted on 26/11/202426/11/2024 by ScienceFather

Assist. Prof. Dr. Chun-Feng Huang | Health Professions | Best Researcher Award

Chief of Family Medicine at En Chu Kong Hospital/National Yang Ming Chiao Tung University, Taiwan

Dr. Chun-Feng Huang is an Assistant Professor at the National Yang Ming Chiao Tung University and the Chief of Family Medicine at En Chu Kong Hospital. With a rich academic background, including a Ph.D. from Taipei Medical University and an MD from National Yang Ming Chiao Tung University, Dr. Huang is a certified expert in Family Medicine, Hospice and Palliative Medicine, and Osteoporosis. His research spans metabolomics, precision medicine, gerontology, and osteoporosis, with numerous publications in reputable journals. 🌊🔬.

Publication Profile

Education

Dr. Chun-Feng Huang earned his Doctor of Medicine degree from the National Yang Ming Chiao Tung University, School of Medicine, Taiwan. He further specialized by obtaining a Ph.D. from Taipei Medical University’s Graduate Institute of Clinical Medicine. Complementing his advanced education, Dr. Huang holds various board certifications: Family Medicine, Hospice and Palliative Medicine, Integrative Medicine, and Osteoporosis. Additionally, he is a Certified Clinical Densitometrist accredited by the International Society for Clinical Densitometry (ISCD). His academic journey reflects a deep commitment to continuous learning and specialization in both clinical and research domains, equipping him with a robust foundation to tackle complex medical challenges. Dr. Huang’s educational background not only highlights his expertise in medicine but also underscores his dedication to advancing patient care through education, research, and clinical excellence.

Experience

Dr. Chun-Feng Huang’s career is marked by influential roles in academia and clinical practice. He currently serves as an Assistant Professor at the National Yang Ming Chiao Tung University and Chief of the Department of Family Medicine at En Chu Kong Hospital. Previously, he directed the Department of Family Medicine at the same university hospital from 2016 to 2022. His leadership extended to chairing healthcare services for correctional institutions and community development associations. As Deputy Secretary General and former Prevention Committee Deputy Chairman of the Taiwan Association of Family Medicine, Dr. Huang has shaped national health policies. He also contributed as a Director for the Taipei Smart City IoT Association. His experience in reviewing medical policies for Taiwan’s FDA and involvement in mountain healthcare projects demonstrates his dedication to improving public health systems and addressing diverse healthcare needs through integrated solutions.

Awards and Honors

Dr. Chun-Feng Huang has received numerous accolades for his contributions to medicine and community health. He was recognized with the First Prize at the Annual Academic Conference by the Taiwan Association of Family Medicine in both 2011 and 2018. Between 2010 and 2017, he served as the Principal Investigator for key projects, including the Mountain and Offshore Healthcare Plan and healthcare services for correctional institutions. His leadership was also acknowledged as Chairman of the Yilan County Kang Tai Community Development Association and as Director of the Taipei Smart City IoT Association. His continuous service to healthcare is highlighted by his role as a reviewer for the Taiwan Food and Drug Administration. These awards and honors underscore his commitment to innovation, excellence in family medicine, and the advancement of public health initiatives.

Research Focus

Dr. Chun-Feng Huang’s research centers on metabolomics, precision medicine, gerontology, and osteoporosis. He explores the intricate connections between metabolic pathways and chronic diseases, aiming to develop personalized medical interventions. His work in precision medicine emphasizes tailoring treatments to individual genetic and environmental factors, particularly for elderly populations. In gerontology, he focuses on improving quality of life and functional health outcomes, with a special interest in sarcopenia and cognitive decline. Dr. Huang is also a leading expert in osteoporosis research, contributing to guidelines for fracture prevention and management. His studies include the effects of medications on bone health and the development of innovative treatments to reduce mortality in osteoporosis patients. Through multidisciplinary collaborations, he aims to bridge clinical research with practical healthcare solutions, advancing the understanding and management of age-related diseases.

Conclusion

Dr. Chun-Feng Huang is an outstanding candidate for the Best Researcher Award. His prolific research output, leadership roles, and clinical impact demonstrate excellence and dedication. Addressing the suggested areas for improvement could further elevate his contributions, but his current achievements already position him as a leading figure in his field.

Publication Top Notes

Nicotinuric acid: a potential marker of metabolic syndrome through a metabolomics-based approach

Authors: CF Huang, ML Cheng, CM Fan, CY Hong, MS Shiao

Citations: 57

Year: 2013

Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomised controlled trial

Authors: WJ Lee, LN Peng, CH Lin, RC Chen, SZ Lin, CH Loh, SL Kao, TS Hung, …

Citations: 55

Year: 2021

Heat stress responses modulate calcium regulations and electrophysiological characteristics in atrial myocytes

Authors: YC Chen, YH Kao, CF Huang, CC Cheng, YJ Chen, SA Chen

Citations: 38

Year: 2010

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Authors: TW Tai, CF Huang, HK Huang, RS Yang, JF Chen, TT Cheng, FP Chen, …

Citations: 29

Year: 2023

Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study

Authors: TW Tai, CC Li, CF Huang, WP Chan, CH Wu

Citations: 24

Year: 2022

Mononucleated and binucleated cardiomyocytes in left atrium and pulmonary vein have different electrical activity and calcium dynamics

Authors: CF Huang, YC Chen, HI Yeh, SA Chen

Citations: 22

Year: 2012

Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: Systemic review and meta-analysis

Authors: CH Wu, WC Hung, L Chang, TT Tsai, YF Chang, EV McCloskey, NB Watts, …

Citations: 19

Year: 2020

Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients

Authors: CF Huang, MS Shiao, TY Mao

Citations: 17

Year: 2021

Detection of ventilatory thresholds using near-infrared spectroscopy with a polynomial regression model

Authors: CW Lin, CF Huang, JS Wang, LL Fu, TY Mao

Citations: 15

Year: 2020

First insights on value-based healthcare of elders using ICHOM older person standard set reporting

Zhushanying Zhang | Health Professions | Best Researcher Award

Posted on 20/11/202420/11/2024 by ScienceFather

Assist. Prof. Dr. Zhushanying Zhang | Health Professions | Best Researcher Award

Assist. Prof. Dr. Zhushanying Zhang, South-Central Minzu University, China

Dr. Zhushanying Zhang holds a Ph.D. in Mechanical and Electronic Engineering from the School of Mechanical Science and Engineering, Huazhong University of Science and Technology. His research focuses on infrared spectroscopy detection, machine learning, optoelectronic detection, and fiber optic sensing. Dr. Zhang has led multiple National Natural Science Foundation of China-funded projects and received special funding for basic scientific research. He has published over ten academic papers and holds three invention patents. His work includes advancing Fourier infrared spectroscopy for noninvasive diabetes diagnosis through blood, urine, and saliva samples. 🔬📑💡

Publication Profile

Scopus

Academic and Professional Background

Assist. Prof. Dr. Zhushanying Zhang graduated with a Ph.D. in Mechanical and Electronic Engineering from the School of Mechanical Science and Engineering at Huazhong University of Science and Technology. His research focuses on infrared spectroscopy detection, machine learning, optoelectronic detection, and fiber optic sensing. Dr. Zhang has led and participated in several research projects funded by the National Natural Science Foundation of China, alongside special funding for basic scientific research from central universities. He has published over ten high-quality academic papers as the first or corresponding author and holds three invention patents. 📚💡📑

Research and Innovations

Assist. Prof. Dr. Zhushanying Zhang has led multiple innovative research projects focused on non-invasive detection technologies. His completed projects include the “Highly Accurate Glucose Detection Using Mid-Infrared Absorption Spectroscopy” (2022-2023, 50,000 Yuan) and “Non-invasive Uric Acid Detection by Near-Infrared Spectroscopy” (2018-2020, 40,000 Yuan), both funded by the Fundamental Research Funds for Central Universities. He also presided over the “Non-invasive Detector for Human Weak Components” (2021-2023, 100,000 Yuan) and “Human Saliva Infrared Spectroscopy Detection” (2022-2023, 500,000 Yuan). His work in Fourier infrared spectroscopy offers promising advancements for diabetes diagnosis using blood, urine, and saliva samples. 🧬📊

Research Areas

Assist. Prof. Dr. Zhushanying Zhang’s research spans across multiple cutting-edge fields. His expertise in infrared spectroscopy and fiber optic sensing focuses on non-invasive medical diagnostics, particularly for glucose and uric acid detection. Utilizing machine learning techniques, he enhances the accuracy and efficiency of sensor data analysis. His work in medical sensing aims to revolutionize healthcare by developing innovative detection technologies. Additionally, Dr. Zhang applies chemometrics to optimize data interpretation, advancing the potential of these technologies for real-world applications, especially in diagnostics and healthcare monitoring. 🔍💡📈

Publication Top Notes

“Advances in Fourier infrared spectroscopy for noninvasive diagnosis of diabetes mellitus: Analysis and prospects for application based on blood, urine, and saliva samples” (2024) 📄
“Precise measurement of human heart rate based on multi-channel radar data fusion” (2024) 📄
“A comprehensively improved local binary pattern framework for texture classification” (2024) 📄
“Identifying the Role of Disulfidptosis in Endometrial Cancer via Machine Learning Methods” (2023) 📄 | Cited by 1
“Quantitative Analysis of Hemoglobin Based on SiPLS-BP Model” (2023) 📄 | Cited by 2
“Texture classification combining improved local binary pattern and threshold segmentation” (2023) 📄 | Cited by 12
“Mid-infrared spectroscopy with an effective variable selection method based on MPA for glucose detection” (2023) 📄 | Cited by 5
“Influencing Factors of Mid-Infrared Spectrum Blood Glucose Detection” (2023) 📄 | Cited by 2
“Quantitative Analysis of Hemoglobin Based on SiPLS-SPA Wavelength Optimization” (2023) 📄 | Cited by 3
“Thermal performance of LED filament in flip-chip packaging manufactured for different correlated color temperature” (2021) 📄 | Cited by 1

Luis Sobrevia | Medicine and Dentistry | Best Researcher Award

Posted on 11/11/202411/11/2024 by ScienceFather

Prof. Luis Sobrevia | Medicine and Dentistry | Best Researcher Award

Prof. Luis Sobrevia, Pontificia Universidad Católica de Chile, Chile

Prof. Luis Sobrevia is a distinguished Chilean physiologist with extensive academic and research credentials. He completed his BSc in Biological Sciences from Universidad del Bío-Bío, MSc in Physiological Sciences from Universidad de Concepción, and PhD in Physiology and Biomedicine from King’s College London. He has held postdoctoral training at King’s College London and earned a Diploma in University Teaching from Pontificia Universidad Católica de Chile (PUC). As a Fellow of The Physiological Society (UK) and the International Union of Physiological Sciences, he holds prominent academic positions worldwide, including at PUC, TecSalud in Mexico, and UNESP in Brazil. His research focuses on placental vascular dysfunction in pregnancy complications like gestational diabetes and obesity, studying pathways that affect maternal-fetal health. He has mentored numerous PhD and MSc students and collaborates globally on groundbreaking research. 🌍🔬

Publication Profile

Google Scholar

Education

Prof. Luis Sobrevia holds a BSc Hons. in Biological Sciences (1986) from Universidad del Bío-Bío, Chile, and an MSc in Physiology (1990) from Universidad de Concepción, Chile. He earned his PhD in Physiology and Biomedicine (1996) at King’s College London, UK, followed by a postdoctoral fellowship there. Prof. Sobrevia has held academic positions globally, currently serving as a Distinguished Research Professor at Tecnológico de Monterrey, Mexico, and as an Honorary Professor in Australia, Spain, and Brazil. His extensive experience spans physiology, biomedicine, and university teaching, making significant contributions to obstetrics and biomedical sciences. 🏥📚

Research

Prof. Luis Sobrevia leads an extensive research group comprising PhD students from various global institutions, such as PUC Chile, U Talca, UNESP Brazil, and U Coimbra, Portugal. His team includes MSc and undergraduate students, along with technical research assistants like biochemist K Silva. The group hosts postdoctoral researchers, including A Grismaldo and MA Pascon. Collaborations span prestigious institutions like University Medical Centre Groningen, TecSalud, and Karolinska Institutet. As a thesis supervisor, Prof. Sobrevia has mentored 69 students across PhD, MSc, and undergraduate levels, focusing on physiology, biomedicine, and molecular biology. 🌍📚💡

Teaching Experience 🎓📚

Prof. Luis Sobrevia is a dedicated educator, teaching undergraduate courses in Medicine, Biology, Biochemistry, Nutrition, and Bioethics. He also mentors postgraduate students, including PhD, MSc, and medical specialization programs. His teaching spans top universities in Chile (PUC, UCH, UT, UA, UACH, UDEC) and internationally at institutions like UMCG (Netherlands), US (Spain), KCL (UK), AUT (New Zealand), UQCCR (Australia), UNESP (Brazil), and TecMonterrey (Mexico). His expertise covers topics such as gestational diabetes, fetal vascular dysfunction, cardiovascular pathophysiology, endothelial physiology, and insulin and adenosine signaling. 🌍🩺📖

Academic and Scientific Merit Recognitions 🌟🏅

Prof. Luis Sobrevia has earned numerous prestigious awards and appointments throughout his academic career. In 2024, he was nominated as a Corresponding Member of the Chilean Academy of Sciences and recognized for his contributions to internationalization by the Mexican Society of Physiological Sciences. He was also appointed Co-president of the Regional Focal Point for Latin America and the Caribbean (RFP-LAC) of the International Science Council (ISC) and Editor-in-Chief of Physiological Minireviews. His leadership extends to roles such as Regional Editor for The Journal of Physiology and member of international scientific committees, highlighting his significant global impact. 🌍📚💡

Publication Top Notes

Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells by GE Mann, DL Yudilevich, L Sobrevia, Physiological reviews 83 (1), 183-252, Cited by: 578, 2003 📚💉
A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration by C Salomon, MJ Torres, M Kobayashi, K Scholz-Romero, L Sobrevia, PloS one 9 (6), e98667, Cited by: 412, 2014 🤰🔬
Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis by C Salomon, J Ryan, L Sobrevia, M Kobayashi, K Ashman, M Mitchell, PloS one 8 (7), e68451, Cited by: 400, 2013 🌱💧
Oxidative stress: Normal pregnancy versus preeclampsia by DI Chiarello, C Abad, D Rojas, F Toledo, CM Vázquez, A Mate, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (2), 165354, Cited by: 325, 2020 🩸💔
Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes by C Salomon, M Kobayashi, K Ashman, L Sobrevia, MD Mitchell, GE Rice, PloS one 8 (11), e79636, Cited by: 213, 2013 🌍💫
Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia by L Sobrevia, GE Mann, Experimental Physiology: Translation and Integration 82 (3), 423-452, Cited by: 208, 1997 🧬🩺
Activation of L‐arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells by L Sobrevia, A Nadal, DL Yudilevich, GE Mann, The Journal of physiology 490 (3), 775-781, Cited by: 204, 1996 ⚡💡
Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy by SD Calligaris, M Lecanda, F Solis, M Ezquer, J Gutierrez, E Brandan, PloS one 8 (4), e60931, Cited by: 189, 2013 🍔❤️
Extracellular vesicles in obesity and diabetes mellitus by F Pardo, R Villalobos-Labra, B Sobrevia, F Toledo, L Sobrevia, Molecular aspects of medicine 60, 81-91, Cited by: 187, 2018 🧬🍩
Early activation of the p42/p44MAPK pathway mediates adenosine‐induced nitric oxide production in human endothelial cells: a novel calcium‐insensitive … by AW Wyatt, JR Steinert, CPD Wheeler‐Jones, AJ Morgan, D Sugden, The FASEB journal 16 (12), 1584-1594, Cited by: 155, 2002 🔬💡

Haojie Shan | Medicine and Dentistry | Best Researcher Award

Posted on 04/11/202404/11/2024 by ScienceFather

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. 📚🏆🦴

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. 🦴🎓🏥

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. 🦴🔬💉✨

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. 🥇🏆🎖️✨

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

Publication Top Notes

A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm – Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations 📜
Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections – Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations 💉
An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing – Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
Scd-1 deficiency promotes the differentiation of CD8+ T effector – Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation 💉
Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways – Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations ⚖️
Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α – Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦵
The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis – Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination – Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations 🔬
Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis – Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptor – Wu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱

Fei Yu | Medicine and Dentistry | Best Researcher Award

Posted on 29/10/202429/10/2024 by ScienceFather

Fei Yu | Medicine and Dentistry | Best Researcher Award

Prof Fei Yu, Shanghai tenth people’s hospital, China

Prof. Fei Yu, a distinguished expert in Nuclear Medicine, holds a rich educational background with degrees from Soochow University and Fudan University. With a graduation date of June 2012 from Soochow University School of Medicine, he has dedicated himself to advancing the field of Nuclear Medicine through significant contributions and research.

Publication profile

Scopus

Education

Prof. Fei Yu graduated in June 2012 from Soochow University, where he completed his medical education. He previously attended Fudan University from September 1996 to July 2001, earning his degree from the School of Public Health and Community Medicine. Furthering his studies, Prof. Yu obtained his degree from Tongji University’s School of Medicine between March 2005 and March 2008. With a strong foundation in public health and medicine, he has made significant contributions to his field. 🌍📚🏥

Honors and Awards

Prof. Fei Yu is a distinguished researcher recognized for his significant contributions to nuclear medicine. He was awarded the Star of Hope Award by the Chinese Society of Nuclear Medicine in September 2018. His project on targeted therapy for non-small cell lung cancer, supported by the Shanghai Talent Development Fund in September 2017, highlights his innovative approach in the field. He also received the Shanghai Science and Technology Award in November 2010 for developing a 99mTc labeled somatostatin receptor imaging kit for lung cancer diagnosis. Additionally, he was honored with the Huaxia Medical Science and Technology Award and the Hospital Technology Innovation Award for his research on medical ethics and intelligent clinical pathways. 🌟🔬🏆

Research Achievements

Dr. Yang and colleagues have made significant strides in cancer therapy and cardiology. Their 2024 study in Theranostics explores how damaged mitochondrial transfer impacts the bystander effect induced by alpha-particle radiation (🎗️). Another study published in Small reveals that alpha-emitter Radium-223 triggers STING-dependent pyroptosis, enhancing antitumor immunity (💉). Additionally, they developed alpha radionuclide-chelated radioimmunotherapy promoters to advance local radiotherapy strategies, published in Biomaterials Research (📚). In cardiology, their nomogram for predicting major adverse cardiac events in patients with ischemia, featured in Frontiers in Cardiovascular Medicine, is a pivotal contribution (❤️).

Research focus

Prof. Fei Yu is a prominent researcher specializing in nuclear medicine and molecular imaging. His work encompasses the development and evaluation of advanced therapeutic approaches, particularly in the context of neuroendocrine tumors and thyroid cancer. Prof. Yu’s research focuses on innovative treatments like peptide receptor radionuclide therapy and the mechanisms of antitumor immunity, including the role of STING-dependent pyroptosis induced by alpha-emitter Radium-223. His contributions significantly enhance understanding of cancer therapies and their implications for patient prognosis. 🔬💉📈

Memberships and Leadership

Prof. Yu is an active member of several professional societies, holding key positions such as Vice Chairman of the Continuing Education Committee of Nuclear Medicine under the Chinese Nuclear Society. His involvement in these organizations reflects his dedication to the growth and education within the field, emphasizing the importance of collaboration and knowledge sharing.

Funding and Research Projects

Prof. Yu leads multiple funded projects, including the National Natural Science Foundation project on interstitial radiotherapy combined with immunotherapy for non-small cell lung cancer. His work is characterized by a strong focus on innovative therapies that integrate radiological techniques with emerging treatment modalities.

Publication top notes

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity

Conclusion

Prof. Fei Yu exemplifies excellence in nuclear medicine, with a career marked by substantial research contributions, leadership roles, and a commitment to advancing medical science. His innovative approaches to cancer therapy and active involvement in professional societies make him an outstanding candidate for the Best Researcher Award. Prof. Yu’s dedication to improving patient outcomes through research and education sets a high standard for future professionals in the field.

Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Posted on 22/10/202422/10/2024 by ScienceFather

Dr. Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Dr. Miguel Virseda-Chamorro, Hospital Nacional de parapléjicos, Spain

Dr. Miguel Virseda-Chamorro is a distinguished urologist with extensive expertise in urodynamics and pelvic floor disorders. He earned his MD from the University of Valencia in 1981 and specialized in Urology at Gómez Ulla Hospital in 1990. He holds a PhD, awarded cum laude in 1992, and completed further education in Health Sciences Statistics. Dr. Virseda is a Fellow of the European Board of Urology and has contributed to major scientific journals. Recognized with several prestigious awards, his research has impacted functional urology and neurogenic bladder treatment. He is fluent in multiple languages and an active member of several urological societies. 🏥🧬📊

Publication Profile

Scopus

Orcid

Academic Formation and Specializations

Dr. Virseda-Chamorro has an impressive academic trajectory, beginning with a Licenciatura in Medicine and Surgery from the University of Valencia (1981) and multiple specialized courses in Urology and Medical Aeronautics. He has also pursued advanced degrees, including a Master in Health Sciences Design and Statistics (2001), which supports his clinical research. His PhD in Urology, awarded with distinction, further underscores his expertise in the field.

Awards and Distinctions

His outstanding contributions have been recognized through several prestigious awards, such as the Best Doctoral Thesis Awards (1992, 1995), and multiple honors from the Spanish Urology Association for his groundbreaking research. These recognitions validate his impact on the field of urology, particularly in areas like urodynamic models and pelvic prolapse treatment.

Teaching and Clinical Trials

Dr. Virseda-Chamorro has also made significant contributions to medical education, leading various courses on pelvic floor treatment and urodynamic pediatric pathologies. His participation in numerous clinical trials, such as evaluating the efficacy of beta-3 agonists for overactive bladder, shows his ongoing commitment to advancing medical knowledge and patient care.

Conclusion

Dr. Miguel Virseda-Chamorro’s rich academic background, clinical expertise, significant research contributions, and numerous honors make him an ideal candidate for the Best Researcher Award. His dedication to both clinical practice and advancing scientific understanding in urology highlights his qualification for this prestigious recognition.

Ivan Medina | Health Professions | Best Researcher Award

Posted on 21/10/202421/10/2024 by ScienceFather

Ivan Medina | Health Professions | Best Researcher Award

Prof Ivan Medina, Universidad de Málaga, Spain

Prof. Ivan Medina-Porqueres is a distinguished expert in Physical Therapy with over 20 years of experience at the University of Malaga, where he teaches courses such as Musculoskeletal Assessment and Manual Therapy. He holds advanced master’s degrees in Sports Physiotherapy and Research in Sports & Physical Activity. With over 70 publications, his research focuses on clinical assessment, sports injuries, and innovative therapies like Platelet-Rich Plasma treatment. An active member of professional organizations, he frequently speaks at conferences, reflecting his commitment to advancing physiotherapy. Prof. Medina’s work significantly enhances clinical practice and patient care. 🎓🩺📚✨

Publication Profile

Google Scholar

Academic and Professional Background

Prof. Medina has over 20 years of experience in the field of Physical Therapy and has played a significant role in teaching courses like Musculoskeletal Assessment, Kinesiology, Anatomy, and Manual Therapy at the University of Malaga. His educational background, including advanced master’s degrees in Sports Physiotherapy, Manual Therapy, and Research in Sports & Physical Activity, establishes him as an expert in his field.

CAREER PROFILE

Experienced physical therapist with a rich academic and administrative background in university-based settings, actively involved in various sports disciplines since 1998. Demonstrates a proven ability to ensure safe, quality patient care while building productive teams and effectively managing administrative and financial tasks. Committed to achieving corporate objectives, with well-developed interpersonal skills that foster leadership in team-oriented environments. Current clinical expertise and recent publications enhance a contemporary approach to patient care, ensuring that practices remain relevant and effective. Prof. Ivan Medina-Porqueres continues to contribute positively to both academic and clinical landscapes. 🏥🎓💪📈

Research Focus

Prof. Ivan Medina-Porqueres focuses his research on the field of physiotherapy, with particular expertise in musculoskeletal injuries, sports rehabilitation, and innovative treatment modalities. His significant contributions include studies on the effectiveness of acupuncture, eccentric exercise therapy, and platelet-rich plasma in managing various conditions like shoulder impingement, osteoarthritis, and fibromyalgia. He emphasizes clinical assessment and therapeutic exercises for recovery training, addressing issues such as myofascial pain and pelvic floor health. Prof. Medina’s work is influential in advancing clinical practices and improving patient outcomes, solidifying his role as a key figure in contemporary physiotherapy research. 🏋️‍♂️📚💉💪

Publication Top Notes

Single-point acupuncture and physiotherapy for the treatment of painful shoulder: a multicentre randomized controlled trial

TENDÓN. Valoración y tratamiento en fisioterapia

Effectiveness of the eccentric exercise therapy in physically active adults with symptomatic shoulder impingement or lateral epicondylar tendinopathy: a systematic review

Anterior Cruciate Ligament Strain In Vivo: A Systematic Review

Physical examination tests for the diagnosis of femoroacetabular impingement. A systematic review

Manual de pruebas diagnosticas

En: Manual de pruebas diagnósticas

Conclusion

With his extensive experience, significant contributions to research, and dedication to education and community engagement, Prof. Ivan Medina-Porqueres is a highly deserving candidate for the Best Researcher Award. His work not only advances knowledge in physiotherapy but also enhances clinical practice and patient care.

Mahmoud Ramadan | Medicine and Dentistry | Outstanding Scientist Award

Posted on 05/10/202405/10/2024 by ScienceFather

Assoc Prof Dr. Mahmoud Ramadan | Medicine and Dentistry | Outstanding Scientist Award

Associate Professor at College of Medicine, University of Sharjah, United Arab Emirates

Dr. Mahmoud Ramadan is an accomplished Clinical Associate Professor with extensive expertise in cardiovascular medicine and cardiology. He holds a Doctorate in Cardiovascular Medicine from Niigata University, Japan, and has been involved in various academic and clinical roles, currently serving at both the University of Sharjah in the UAE and Mansoura University in Egypt. With multiple certifications in cardiology and significant research experience, including participation in the global INTERHEART study, Dr. Ramadan has contributed numerous publications to esteemed journals. His proficiency in statistical analysis, languages, and various medical certifications underscores his dedication to advancing cardiovascular health and education.

Publication profile

Scopus Profile

Education Background

Dr. Mahmoud Ramadan holds an extensive educational background in the field of medicine, particularly in cardiovascular medicine. He earned his Doctorate Degree in Cardiovascular Medicine from Niigata University Graduate School of Medical and Dental Sciences in Japan, graduating in September 2008. His doctoral thesis focused on the “Impact of Percutaneous Coronary Intervention on the Levels of Interleukin-6 and C-Reactive Protein in the Coronary Circulation of Subjects with Coronary Artery Disease.” Prior to this, he completed his Master’s degree in Cardiology at Mansoura University, Egypt, where he graduated in May 2001, and his undergraduate degree, M.B.B.Ch., from the same institution in November 1995, graduating with honors. Additionally, Dr. Ramadan has pursued further professional development, obtaining various certifications, including MRCP (UK) and other specialized courses in areas such as echocardiography, abdominal ultrasonography, and atherosclerosis, thereby reinforcing his expertise in the medical field.

Research Experience

Dr. Mahmoud Ramadan has extensive research experience in cardiovascular medicine, evidenced by his impactful work as a Clinical Associate Professor and multiple roles in renowned medical institutions. He earned his PhD from Niigata University, Japan, where he explored the effects of percutaneous coronary interventions on inflammatory markers in patients with coronary artery disease. His involvement in the global “INTERHEART” study significantly contributed to understanding myocardial infarction risk factors across various populations. Dr. Ramadan has published numerous original research articles in prestigious journals, focusing on topics such as cardiac dysfunction, coronary disease, and inflammatory responses, showcasing his dedication to advancing cardiovascular science. Additionally, he has supervised both master’s and PhD students, further demonstrating his commitment to fostering future research talent in the field.

Teaching and Mentoring Experience

Dr. Mahmoud Ramadan has extensive teaching and mentoring experience in the field of cardiology and medicine. As an Associate Professor of Medicine at the University of Sharjah and the Faculty of Medicine at Mansoura University, he has contributed significantly to the education of medical students and residents. He has lectured on various topics in cardiology, sharing his expertise and fostering critical thinking among students. Additionally, Dr. Ramadan has supervised numerous master’s and PhD students, guiding them through their research projects and dissertations, which demonstrates his commitment to nurturing the next generation of medical professionals. His role as an AHA-certified instructor in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS) further underscores his dedication to teaching practical skills that are essential in clinical settings. Through his mentorship and teaching, he has played a vital role in shaping the educational landscape in cardiology, emphasizing the importance of both theoretical knowledge and hands-on experience.

Work Experience

Dr. Mahmoud Ramadan has an extensive work experience in the field of cardiology and medicine, spanning over two decades. He currently serves as an Associate Professor of Medicine in the Clinical Sciences Department at the University of Sharjah, UAE, and holds a similar position at Mansoura University in Egypt. His professional journey began as a House Officer at Mansoura University Hospitals, followed by various roles including Resident Physician, Assistant Lecturer, and Lecturer in Cardiology at Mansoura University. Throughout his career, he has engaged in advanced clinical training in Japan and contributed significantly to teaching, supervision, and research in cardiovascular medicine. Additionally, Dr. Ramadan is involved in multiple professional certifications, training programs, and has contributed to several international collaborative studies, showcasing his commitment to advancing medical knowledge and practice in cardiology.

Awards, Honours & Certificates

Dr. Mahmoud Ramadan has received several prestigious awards and honors throughout his academic and professional career. Notably, he was selected as a representative of Mansoura University in the global INTERHEART study, which was published in The Lancet. He also earned the esteemed Japanese Government Monbu-Kagakusho Scholarship for his PhD in Cardiology from Niigata University. In addition, Dr. Ramadan was recognized as a Young Investigator Award Finalist at the 22nd Annual Meeting of the Japanese Section of the International Society of Heart Research. His accolades include the EJISST Award at the First Egypt-Japan International Symposium on Science and Technology and the JSPS Post-Doctoral Fellowship from the Japan Society for the Promotion of Science in 2008. His commitment to continued education is evidenced by his completion of various certifications, including in mechanical ventilation and echocardiography, as well as his membership in several distinguished medical associations.

Publication Top Notes

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
- Authors: Brauer, M., Roth, G.A., Aravkin, A.Y., Murray, C.J.L., Gakidou, E.
- Year: 2024
- Citations: 66
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
- Authors: Ferrari, A.J., Santomauro, D.F., Aali, A., Vos, T., Murray, C.J.L.
- Year: 2024
- Citations: 107
Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement
- Authors: Alsereidi, F.R., Khashim, Z., Marzook, H., Ramadan, M.M., Saleh, M.A.
- Year: 2024
- Citations: 4
Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
- Authors: Sirota, S.B., Doxey, M.C., Dominguez, R.-M.V., Murray, C.J.L., Kyu, H.H.
- Year: 2024
- Citations: 1
Alchemilla vulgaris modulates isoproterenol-induced cardiotoxicity: interplay of oxidative stress, inflammation, autophagy, and apoptosis
- Authors: Anajirih, N., Abdeen, A., Taher, E.S., Ramadan, M.M., Habotta, O.A.
- Year: 2024
- Citations: 0

Conclusion

Dr. Mahmoud Ramadan exemplifies the qualities of an outstanding researcher in cardiovascular medicine. His strong academic background, extensive research contributions, and clinical expertise make him a deserving candidate for the Best Researcher Award. By focusing on expanding his research scope, increasing outreach, diversifying research methodologies, and embracing innovative trends, he can further enhance his impact in the field. Awarding him this recognition would not only honor his past contributions but also encourage future advancements in cardiovascular research and patient care.

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Posted on 23/09/202423/09/2024 by ScienceFather

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Dr Hong De Sa, OHSU, United States

Based on Dr. Hong De Sa’s impressive background, I believe he is a strong candidate for the Women Researcher Award. Here are key points that highlight his qualifications:

Publication profile

Scopus

Education and Training

Dr. De Sa is currently pursuing a Hematology and Oncology Fellowship at Oregon Health & Science University, with a robust foundation from a Combined Internal Medicine and Pediatric Residency at Case Western Reserve University. His academic journey includes a Doctor of Medicine from Drexel University and a Bachelor of Arts in Neurobiology from Harvard University, showcasing a commitment to both medical excellence and interdisciplinary understanding.

Leadership and Experience

As Chief Fellow for the 2024-2025 academic year, Dr. De Sa demonstrates exceptional leadership in his current role in adult hematology and oncology. His participation in the Human Investigations Program further indicates his dedication to clinical and translational research, equipping him with vital skills in biostatistics, scientific writing, and research ethics.

Research Contributions

Dr. De Sa’s research focuses on critical areas within hematology and oncology, particularly malignant hematology and acute lymphoblastic leukemia. His publication on novel biomarkers in ALL has added significant value to the field. Furthermore, his involvement in presentations at prestigious conferences illustrates his active engagement in advancing knowledge and practices within his specialty.

Awards and Recognition

Dr. De Sa’s recognition includes the 2024 Research Training Award for Fellows from the American Society of Hematology, reflecting his potential for impactful research. His previous honors, such as the Byron R. Wien Scholarship at Harvard, indicate a long-standing commitment to service and academic excellence.

Community Engagement and Service

His service-oriented mindset is exemplified by awards recognizing his contributions to health outreach and public service initiatives during his educational journey, underscoring his dedication to improving community health outcomes.

Extracurricular Achievements

Dr. De Sa’s achievements in ultramarathoning showcase his discipline and resilience, qualities that translate well into the rigorous demands of research and clinical practice.

conclusion

Dr. Hong De Sa’s extensive training, leadership roles, research contributions, recognition, and commitment to service make him an outstanding candidate for the Women Researcher Award. His multifaceted approach to medicine and research aligns perfectly with the values and standards of this prestigious recognition.